Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

Tea will be served at 10:15 a.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

Tea will be served at 1:45 p.m., immediately preceding the seminar.AudienceThis seminar is open to the research community.

A five-year study has found that adding daratumumab (D) to the current standard-of-care triplet therapy bortezomib, lenalidomide, and dexamethasone (VRd) produced deeper and more durable minimal ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Mara Sherman, PhD, was awarded the Mark Foundation 2025 Emerging Leader Award, which honored five early-career scientists ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Las mediciones de presión arterial que tome en casa ayudarán a su equipo de atención a tomar decisiones sobre su atención. Las mediciones pueden ayudar a diagnosticar la hipertensión. Además, su ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Zenocutuzumab is a novel bispecific antibody designed by Merus, N.V. In a multicenter global phase 2 clinical trial led by MSK gynecologic medical oncologist and early drug development specialist ...